TITLE 25. HEALTH SERVICES

PART 11. CANCER PREVENTION AND RESEARCH INSTITUTE OF TEXAS

CHAPTER 701. POLICIES AND PROCEDURES

25 TAC §701.37

The Cancer Prevention and Research Institute of Texas ("CPRIT" or "the Institute") adopts new §701.37 without changes to the proposed text as published in the December 15, 2017, issue of the Texas Register (42 TexReg 7090). The new rule sets travel policy requirements for grant recipients.

Reasoned Justification

The adopted new rule §701.37 requires grant recipients to follow the requirements of the State of Texas travel policy administered by the Texas Comptroller of Public Accounts in order for travel expenses to be reimbursed with CPRIT grant award funds. The new rule also describes the appropriate documentation that must be submitted to support travel expense reimbursement requests and provides guidance regarding special requirements for international travel expenses to be reimbursed with CPRIT grant funds.

Summary of Public Comments and Staff Recommendation

CPRIT received no public comments regarding §701.37.

The new rule is adopted under the authority of the Texas Health and Safety Code Annotated, §102.108, which provides the Institute with broad rule-making authority to administer the chapter, including rules for awarding grants.

The agency certifies that legal counsel has reviewed the adoption and found it to be a valid exercise of the agency's legal authority.

Filed with the Office of the Secretary of State on February 23, 2018.

TRD-201800736

Heidi McConnell

Chief Operating Officer

Cancer Prevention and Research Institute of Texas

Effective date: March 15, 2018

Proposal publication date: December 15, 2017

For further information, please call: (512) 305-8487


CHAPTER 703. GRANTS FOR CANCER PREVENTION AND RESEARCH

25 TAC §703.26

The Cancer Prevention and Research Institute of Texas ("CPRIT" or "the Institute") adopts the amendment to §703.26 without changes to the proposed text as published in the December 15, 2017, issue of the Texas Register (42 TexReg 7091). The amendment expands the list of unallowable costs to include payments by a grant recipient to a subcontractor that employs a relative of the grant recipient's key personnel working on the same project.

Reasoned Justification

The adopted change to §703.26(e) prohibits payment by a grant recipient to a subcontractor if the subcontractor employs an individual who is a relative, as defined by Texas Administrative Code §701.3(57), of key personnel employed by the grant recipient and working on the same grant project. The expense is unallowable if the grant recipient uses grant funds to pay the subcontractor for any portion of the relative's salary or if the relative is responsible for submitting on behalf of the subcontractor expenses for payment by the grant recipient. The grant recipient may request that the Institute's Chief Executive Officer allow an exception to pay a subcontractor that employs a relative. If the Chief Executive Officer grants an exception, he must notify the Oversight Committee in writing. If a grant recipient has stricter internal policies concerning this issue than set forth in the adopted amendment, the rule will not supersede those internal policies. The purpose of this adopted amendment is to reduce potential conflicts of interest between a grant recipient and a subcontractor.

Summary of Public Comments and Staff Recommendation

CPRIT received no public comments regarding the proposed amendment to §703.26.

The amendment is adopted under the authority of the Texas Health and Safety Code Annotated, §102.108, which provides the Institute with broad rule-making authority to administer the chapter, including rules for awarding grants.

The agency certifies that legal counsel has reviewed the adoption and found it to be a valid exercise of the agency's legal authority.

Filed with the Office of the Secretary of State on February 23, 2018.

TRD-201800739

Heidi McConnell

Chief Operating Officer

Cancer Prevention and Research Institute of Texas

Effective date: March 15, 2018

Proposal publication date: December 15, 2017

For further information, please call: (512) 305-8487